eLife (Jul 2022)

Impaired astrocytic Ca2+ signaling in awake-behaving Alzheimer’s disease transgenic mice

  • Knut Sindre Åbjørsbråten,
  • Gry HE Syverstad Skaaraas,
  • Céline Cunen,
  • Daniel M Bjørnstad,
  • Kristin M Gullestad Binder,
  • Laura Bojarskaite,
  • Vidar Jensen,
  • Lars NG Nilsson,
  • Shreyas B Rao,
  • Wannan Tang,
  • Gudmund Horn Hermansen,
  • Erlend A Nagelhus,
  • Ole Petter Ottersen,
  • Reidun Torp,
  • Rune Enger

DOI
https://doi.org/10.7554/eLife.75055
Journal volume & issue
Vol. 11

Abstract

Read online

Increased astrocytic Ca2+ signaling has been shown in Alzheimer’s disease mouse models, but to date no reports have characterized behaviorally induced astrocytic Ca2+ signaling in such mice. Here, we employ an event-based algorithm to assess astrocytic Ca2+ signals in the neocortex of awake-behaving tg-ArcSwe mice and non-transgenic wildtype littermates while monitoring pupil responses and behavior. We demonstrate an attenuated astrocytic Ca2+ response to locomotion and an uncoupling of pupil responses and astrocytic Ca2+ signaling in 15-month-old plaque-bearing mice. Using the genetically encoded fluorescent norepinephrine sensor GRABNE, we demonstrate a reduced norepinephrine signaling during spontaneous running and startle responses in the transgenic mice, providing a possible mechanistic underpinning of the observed reduced astrocytic Ca2+ responses. Our data points to a dysfunction in the norepinephrine–astrocyte Ca2+ activity axis, which may account for some of the cognitive deficits observed in Alzheimer’s disease.

Keywords